Pfizer Inc.
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 63.6B 58.5B 100.3B 81.3B
Cost of revenue 17.9B 25.0B 34.3B 30.8B
Gross profit 45.8B 33.5B 66.0B 50.5B
Operating expense
Research & development 10.9B 10.7B 11.4B 10.4B
Selling general and admin 14.7B 14.8B 13.7B 12.7B
Other operating expenses
Operating income 14.8B 3.4B 37.3B 23.7B
Non operating interest income
Income 545M 1.6B 251M 36M
Expense 3.1B 2.2B 1.2B 1.3B
Other income expense -4.3B -1.7B -1.6B 1.8B
Pretax income 8.0B 1.1B 34.7B 24.3B
Tax provision -28M -1.1B 3.3B 1.9B
Net income 8.1B 2.2B 31.4B 22.0B
Basic EPS 1.4 0.4 5.6 3.9
Diluted EPS 1.4 0.4 5.5 3.9
Basic average shares 5.7B 5.6B 5.6B 5.6B
Diluted average shares 5.7B 5.6B 5.6B 5.6B
EBITDA 22.6B 14.4B 45.1B 33.6B
Net income from continuing op. 8.1B 2.2B 31.4B 22.5B
Minority interests -31M -39M -35M -45M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 2 hours 36 minutes

06:53
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).